828 related articles for article (PubMed ID: 17623664)
21. Co-receptor requirements for fibroblast growth factor-19 signaling.
Wu X; Ge H; Gupte J; Weiszmann J; Shimamoto G; Stevens J; Hawkins N; Lemon B; Shen W; Xu J; Veniant MM; Li YS; Lindberg R; Chen JL; Tian H; Li Y
J Biol Chem; 2007 Oct; 282(40):29069-72. PubMed ID: 17711860
[TBL] [Abstract][Full Text] [Related]
22. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression.
Song KH; Li T; Owsley E; Strom S; Chiang JY
Hepatology; 2009 Jan; 49(1):297-305. PubMed ID: 19085950
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of a cell model expressing βKlotho for screening FGF21 analogues.
Guo X; Wang X; Yuan Q; Wu C; Gao H; Xu P; Liu M; Wang N; Li D; Ren G
Cytotechnology; 2019 Oct; 71(5):1033-1041. PubMed ID: 31535308
[TBL] [Abstract][Full Text] [Related]
24. Liver-specific activities of FGF19 require Klotho beta.
Lin BC; Wang M; Blackmore C; Desnoyers LR
J Biol Chem; 2007 Sep; 282(37):27277-27284. PubMed ID: 17627937
[TBL] [Abstract][Full Text] [Related]
25. βKlotho is required for fibroblast growth factor 21 effects on growth and metabolism.
Ding X; Boney-Montoya J; Owen BM; Bookout AL; Coate KC; Mangelsdorf DJ; Kliewer SA
Cell Metab; 2012 Sep; 16(3):387-93. PubMed ID: 22958921
[TBL] [Abstract][Full Text] [Related]
26. FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia.
Lan T; Morgan DA; Rahmouni K; Sonoda J; Fu X; Burgess SC; Holland WL; Kliewer SA; Mangelsdorf DJ
Cell Metab; 2017 Nov; 26(5):709-718.e3. PubMed ID: 28988823
[TBL] [Abstract][Full Text] [Related]
27. FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways.
Wu AL; Coulter S; Liddle C; Wong A; Eastham-Anderson J; French DM; Peterson AS; Sonoda J
PLoS One; 2011 Mar; 6(3):e17868. PubMed ID: 21437243
[TBL] [Abstract][Full Text] [Related]
28. Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands.
Goetz R; Ohnishi M; Ding X; Kurosu H; Wang L; Akiyoshi J; Ma J; Gai W; Sidis Y; Pitteloud N; Kuro-O M; Razzaque MS; Mohammadi M
Mol Cell Biol; 2012 May; 32(10):1944-54. PubMed ID: 22451487
[TBL] [Abstract][Full Text] [Related]
29. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
[TBL] [Abstract][Full Text] [Related]
30. The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue.
Adams AC; Yang C; Coskun T; Cheng CC; Gimeno RE; Luo Y; Kharitonenkov A
Mol Metab; 2012; 2(1):31-7. PubMed ID: 24024127
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for FGF hormone signalling.
Chen L; Fu L; Sun J; Huang Z; Fang M; Zinkle A; Liu X; Lu J; Pan Z; Wang Y; Liang G; Li X; Chen G; Mohammadi M
Nature; 2023 Jun; 618(7966):862-870. PubMed ID: 37286607
[TBL] [Abstract][Full Text] [Related]
32. Hepatocyte FRS2α is essential for the endocrine fibroblast growth factor to limit the amplitude of bile acid production induced by prandial activity.
Wang C; Yang C; Chang JY; You P; Li Y; Jin C; Luo Y; Li X; McKeehan WL; Wang F
Curr Mol Med; 2014; 14(6):703-711. PubMed ID: 25056539
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast growth factor 21 night watch: advances and uncertainties in the field.
Kharitonenkov A; DiMarchi R
J Intern Med; 2017 Mar; 281(3):233-246. PubMed ID: 27878865
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor 21 secretion enhances glucose uptake in mono(2-ethylhexyl)phthalate-treated adipocytes.
Hsu JW; Yeh SC; Tsai FY; Chen HW; Tsou TC
Toxicol In Vitro; 2019 Sep; 59():246-254. PubMed ID: 31009676
[TBL] [Abstract][Full Text] [Related]
35. Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function.
Williams CM; Harper Calderon J; E H; Jimenez Y; Barringer K; Carbonaro M; Molina-Portela MDP; Thurston G; Li Z; Daly C
FASEB J; 2021 Feb; 35(2):e21286. PubMed ID: 33484478
[TBL] [Abstract][Full Text] [Related]
36. Expression profile and overexpression outcome indicate a role for βKlotho in skeletal muscle fibro/adipogenesis.
Phelps M; Stuelsatz P; Yablonka-Reuveni Z
FEBS J; 2016 May; 283(9):1653-68. PubMed ID: 26881702
[TBL] [Abstract][Full Text] [Related]
37. Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling.
Lee S; Choi J; Mohanty J; Sousa LP; Tome F; Pardon E; Steyaert J; Lemmon MA; Lax I; Schlessinger J
Nature; 2018 Jan; 553(7689):501-505. PubMed ID: 29342135
[TBL] [Abstract][Full Text] [Related]
38. Sustained Brown Fat Stimulation and Insulin Sensitization by a Humanized Bispecific Antibody Agonist for Fibroblast Growth Factor Receptor 1/βKlotho Complex.
Kolumam G; Chen MZ; Tong R; Zavala-Solorio J; Kates L; van Bruggen N; Ross J; Wyatt SK; Gandham VD; Carano RA; Dunshee DR; Wu AL; Haley B; Anderson K; Warming S; Rairdan XY; Lewin-Koh N; Zhang Y; Gutierrez J; Baruch A; Gelzleichter TR; Stevens D; Rajan S; Bainbridge TW; Vernes JM; Meng YG; Ziai J; Soriano RH; Brauer MJ; Chen Y; Stawicki S; Kim HS; Comps-Agrar L; Luis E; Spiess C; Wu Y; Ernst JA; McGuinness OP; Peterson AS; Sonoda J
EBioMedicine; 2015 Jul; 2(7):730-43. PubMed ID: 26288846
[TBL] [Abstract][Full Text] [Related]
39. FGF19 subfamily members: FGF19 and FGF21.
Dolegowska K; Marchelek-Mysliwiec M; Nowosiad-Magda M; Slawinski M; Dolegowska B
J Physiol Biochem; 2019 Jun; 75(2):229-240. PubMed ID: 30927227
[TBL] [Abstract][Full Text] [Related]
40. FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human.
Henriksson E; Andersen B
Front Endocrinol (Lausanne); 2020; 11():601349. PubMed ID: 33414764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
